Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro)
Our results highlight the importance of individualised assessment of cognition, depression, and falls risk in older patients commencing ARPI treatment.
Authors
- A. Smith
- A. Weickhardt
- M. Warren
- M. Arasaratnam
- W. Hong
- P. Gibbs
- S. Rai
- C. Steer
- B. Tran
- A.R.A. Mislang
- A. Linton
- J. J. Torres
- A. Anton
- A.A. Azad
Institutions
- Goulburn Valley Health (AU)
- Flinders University (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Concord Repatriation General Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- Gosford Hospital (AU)
- Flinders Medical Centre (AU)
- Eastern Health (AU)
- Tamworth Hospital (AU)
- Western Health (AU)
- Albury Wodonga Health (AU)
- Goulburn Broken Catchment Management Authority (AU)
- Centre for Cancer Biology (AU)
- Bendigo Health (AU)
- Olivia Newton-John Cancer Wellness & Research Centre (AU)
- Monash University (AU)
Publication Details
- Journal
- ESMO Real World Data and Digital Oncology
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1016/j.esmorw.2025.100677
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00